EN
About us
Research and production center «Micromir» was founded in 2011. Nowadays, Micromir has a well-earned reputation as one of the leaders in the phage therapy research both in Russia and worldwide.
MICROMIR
We initially set out two major issues:
Our mission and achievements
The first one is to develop a line of effective antibacterial drugs for gentle and safe treatment in the early stages of infectious diseases.
The second one is to promote bacteriophage therapy and an ecological perspective on microbiome problems.
1
2
Our history
2011
Company foundation
2011
Creation of our own museum of bacteriophages and host bacteria, registration in the World Federation for Culture Collections (WFCC)
2012
Registration of the first cosmetic products
2013
Transportation of bacteriophages to the International Space Station for research
2016
Industrial Contribution Award at Phage Therapy World Congress in Paris
2019
Registration in Hungary of a veterinary preparation for prevention of bacterial diseases in poultry farming
2019
New research building is put into operation
2019
Cosmetic gel with bacteriophages Iskraphage is registered and delivered to Japan
2020
The first pharmaceutical drug for veterinary use Phagouterin is registered in the Russian Federation
2022
Results of the application of two bacteriophage compositions in the rehabilitation of patients after COVID-19 were published
2022
"Bacteriophages in Urology" guidelines published on the Moscow City Health Department website
2021
As a result of a clinical study conducted jointly with the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, the first experience of using the adaptive phage therapy technique in chronically critically ill patients in neurological intensive care is obtained.
2019
The production building is certified in accordance with GMP standards
2018
New production building is put into operation
2016
Finalist of the Agrogenetics 2016 competition, Skolkovo
2016
The best R&D project at Argofarm 2016
2011
Company foundation
2011
Creation of our own museum of bacteriophages and host bacteria, registration in the World Federation for Culture Collections (WFCC)
2012
Registration of the first cosmetic products
2013
Transportation of bacteriophages to the International Space Station for research
2016
Industrial Contribution Award at Phage Therapy World Congress in Paris
2016
The best R&D project at Argofarm 2016
2016
Finalist of the Agrogenetics 2016 competition, Skolkovo
2018
New production building is put into operation
2019
The production building is certified in accordance with GMP standards
2019
Registration in Hungary of a veterinary preparation for prevention of bacterial diseases in poultry farming
2019
New research building is put into operation
2019
Cosmetic gel with bacteriophages Iskraphage is registered and delivered to Japan
2020
The first pharmaceutical drug for veterinary use Phagouterin is registered in the Russian Federation
2021
As a result of a clinical study conducted jointly with the Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, the first experience of using the adaptive phage therapy technique in chronically critically ill patients in neurological intensive care is obtained.
2022
"Bacteriophages in Urology" guidelines published on the Moscow City Health Department website
2022
Results of the application of two bacteriophage compositions in the rehabilitation of patients after COVID-19 were published in Viruses
With over 120 employees, we have representatives in 10 cities in Russia.
Our products are available in more than
40 cities from Kaliningrad to Khabarovsk.
Our products are available in more than
40 cities from Kaliningrad to Khabarovsk.
We have achieved significant progress in this field through the hard work of our team and strong investments.
Kaliningrad
Khabarovsk
In fact, I started researching bacteriophages in 1975 and joined Micromir's team from its very inception. In order to achieve positive results in phages research field, you firstly need to love them, have deeply understanding of fundamental bacteriophage research and its applications in different fields, and to be, needless to say, a person of integrity. I like the relatively fast positive effect of phage treatment with no complications. The future appears bright for phage-based applications and that's the most inspiring and empowering thing in my work.
Valentina Popova, Deputy General Director in charge of Production
We are for being gentle to the human microbiome and create products according to our priorities and beliefs.
- 7developed and registered products
- 3medicines under development
- over 500a collection of over 500 virulent phages
- over 2000a collection of over 2,000 host bacteria
- over 20cooperation agreements with more than 20 major clinical institutes in Russia
- 12participation in 12 international conferences
- 2016received the industrial contribution award at Phage Therapy World Congress, Paris, 2016
- 2019A new production unit has been built according to the regulations of GMP. The new research and scientific building went into operation in the autumn 2019
Our certificates
© RPC «Micromir»
Veterinary
РЕКВИЗИТЫ
ООО НПЦ «МикроМир»
Адрес: 107031, г. Москва, Кисельный Нижн, д. 5/23, стр. 1
Генеральный Директор: Зурабов Александр Юрьевич
Расчётный счёт
ФИЛИАЛ № 7701 БАНКА ВТБ (ПАО), Москва
Р/c 40702810200000154785
БИК 044525745
К/c 30101810345250000745
ИНН 7702649180
КПП 770201001
ОГРН 1077758802219
ОКПО 82433183
Генеральный Директор: Зурабов Александр Юрьевич
Расчётный счёт
ФИЛИАЛ № 7701 БАНКА ВТБ (ПАО), Москва
Р/c 40702810200000154785
БИК 044525745
К/c 30101810345250000745
ИНН 7702649180
КПП 770201001
ОГРН 1077758802219
ОКПО 82433183
By using this website, you agree to the use of cookies. We use cookies to provide you with a great experience and to help the website run effectively. More information...
OK